Cedarway Pharma Limited in Watford, WD18 9SP

Description

Data updated on: 01-11-2023

Cedarway Pharma is a firm with it's headquarters at WD18 9SP Watford at Unit 3 Moor Park Industrial Centre. This business was formed in 2014 and is established under the identification number 09266066. This business has been operating on the English market for ten years now and the state is active. Since 2014-10-28 Cedarway Pharma Limited is no longer under the name Abacus Pharma. This firm's registered with SIC code 86900 - Other human health activities. The latest annual accounts were submitted for the period up to Thursday 31st March 2022 and the latest annual confirmation statement was released on Thursday 10th November 2022.

There's a group of two directors leading the firm right now, including Abbas M. and Shaheen M. who have been doing the directors responsibilities since October 2014.

Abbas M. is the individual with significant control over this firm, owns 1/2 or less of company shares.

Previous company's names
Cedarway Pharma Limited 2014-10-28
Abacus Pharma Limited 2014-10-15

Financial data based on annual reports

Profit & Loss
Date of Accounts	2016-03-31	2017-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency
Net Worth	4 968	34 585

Balance Sheet
Cash Bank On Hand			367 798	219 942	313 459	166 106	176 439
Current Assets	248 249	220 350	528 242	475 821	469 041	450 275	602 785
Debtors			159 179	234 504	146 466	283 653	425 296
Net Assets Liabilities				178 208	236 184	263 356
Other Debtors			25 154	59 588	31 806	34 086	117 256
Total Inventories			1 265	21 375	9 116	516	1 050
Net Assets Liabilities Including Pension Asset Liability	4 968	34 585

Capital & Reserves
Shareholder Funds	4 968	34 585

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets			2 992	3 740	3 740	3 740
Average Number Employees During Period			2	2	2	2	2
Bank Borrowings Overdrafts					44 167
Corporation Tax Payable			43 141	30 466	26 340	21 386	28 500
Creditors			433 725	297 613	44 167	186 919	289 929
Dividends Paid On Shares			748
Future Minimum Lease Payments Under Non-cancellable Operating Leases			14 910	73 750	58 750	43 750	28 750
Increase From Amortisation Charge For Year Intangible Assets				748
Intangible Assets			748
Intangible Assets Gross Cost			3 740	3 740	3 740	3 740
Net Current Assets Liabilities	1 975	32 078	94 517	178 208	280 351	263 356	312 856
Other Creditors			145 021	4 550	4 309	8 765	32 811
Other Taxation Social Security Payable				828			169
Total Assets Less Current Liabilities	4 968	34 585	95 265	178 208
Trade Creditors Trade Payables			245 563	261 769	152 208	156 768	228 449
Trade Debtors Trade Receivables			134 025	174 916	114 660	249 567	308 040
Called Up Share Capital Not Paid Not Expressed As Current Asset	2	2
Creditors Due Within One Year	246 274	188 272
Fixed Assets	2 991	2 505

Company staff

Abbas M.

Role: Director

Appointed: 15 October 2014

Latest update: 30 December 2023

Shaheen M.

Role: Director

Appointed: 15 October 2014

Latest update: 30 December 2023

People with significant control

Abbas M.

Notified on 1 November 2016

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	24 November 2023
Confirmation statement last made up date	10 November 2022

Annual Accounts 14 July 2016
Start Date For Period Covered By Report	2014-10-15
End Date For Period Covered By Report	2016-03-31
Date Approval Accounts	14 July 2016
Annual Accounts 30 December 2017
Start Date For Period Covered By Report	2016-04-01
End Date For Period Covered By Report	2017-03-31
Date Approval Accounts	30 December 2017
Annual Accounts
Start Date For Period Covered By Report	2019-04-01
End Date For Period Covered By Report	2020-03-31
Annual Accounts
Start Date For Period Covered By Report	2020-04-01
End Date For Period Covered By Report	2021-03-31
Annual Accounts
Start Date For Period Covered By Report	2021-04-01
End Date For Period Covered By Report	2022-03-31
Annual Accounts
Start Date For Period Covered By Report	2022-04-01
End Date For Period Covered By Report	2023-03-31

Cedarway Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Abbas M.

Shaheen M.

Jawad M.

People with significant control

Abbas M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies